Impact of repeated four-monthly anthelmintic treatment on Plasmodium infection in preschool children: a double-blind placebo-controlled randomized trial.
Authors
Kirwan, PatrickJackson, Andrew L
Asaolu, Samuel O
Molloy, Sile F
Abiona, Titilayo C
Bruce, Marian C
Ranford-Cartwright, Lisa
O' Neill, Sandra M
Holland, Celia V
Affiliation
Department of Zoology, University of Dublin, Trinity College, Dublin 2, Ireland. kirwanpa@tcd.ieIssue Date
2010MeSH
AlbendazoleAnimals
Anthelmintics
Ascariasis
Ascaris lumbricoides
Child, Preschool
Double-Blind Method
Female
Humans
Infant
Malaria
Male
Placebos
Treatment Outcome
Metadata
Show full item recordCitation
Impact of repeated four-monthly anthelmintic treatment on Plasmodium infection in preschool children: a double-blind placebo-controlled randomized trial. 2010, 10:277 BMC Infect. Dis.Journal
BMC infectious diseasesDOI
10.1186/1471-2334-10-277PubMed ID
20858280Abstract
Helminth infections can alter susceptibility to malaria. Studies need to determine whether or not deworming programs can impact on Plasmodium infections in preschool children.A double-blind placebo-controlled randomised trial was conducted to investigate the impact of anthelmintic treatment on Plasmodium infection in children aged 12-59 months. Children were randomly assigned to receive either albendazole or placebo every four months for 12 months with a follow-up at 14 months.
320 Children (out of 1228, 26.1%) complied with all the follow-up assessments. Plasmodium prevalence and mean Plasmodium parasite density was significantly higher in the treatment group (44.9% and 2319 ± SE 511) compared to the placebo group (33.3% and 1471 ± 341) at baseline. The odds of having Plasmodium infection increased over time for children in both the placebo and treatment groups, however this increase was significantly slower for children in the treatment group (P = 0.002). By month 14, mean Plasmodium density had increased by 156% in the placebo group and 98% in the treatment group but the rate of change in Plasmodium density was not significantly different between the groups. The change from baseline in haemoglobin had a steeper increase among children in the treatment group when compared to the placebo group but this was not statistically significant.
Repeated four-monthly anthelminthic treatments for 14 months resulted in a significantly lower increase in the prevalence of Plasmodium infection in preschool children which coincided with a reduction in both the prevalence and intensity of A. lumbricoides infections.
Current controlled trials ISRCTN44215995.
Item Type
ArticleLanguage
enISSN
1471-2334ae974a485f413a2113503eed53cd6c53
10.1186/1471-2334-10-277
Scopus Count
Collections
Related articles
- Patterns of soil-transmitted helminth infection and impact of four-monthly albendazole treatments in preschool children from semi-urban communities in Nigeria: a double-blind placebo-controlled randomised trial.
- Authors: Kirwan P, Asaolu SO, Molloy SF, Abiona TC, Jackson AL, Holland CV
- Issue date: 2009 Feb 19
- Impact of single annual treatment and four-monthly treatment for hookworm and Ascaris lumbricoides, and factors associated with residual infection among Kenyan school children.
- Authors: Kepha S, Mwandawiro CS, Anderson RM, Pullan RL, Nuwaha F, Cano J, Njenga SM, Odiere MR, Allen E, Brooker SJ, Nikolay B
- Issue date: 2017 Feb 9
- The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial.
- Authors: Wiria AE, Hamid F, Wammes LJ, Kaisar MM, May L, Prasetyani MA, Wahyuni S, Djuardi Y, Ariawan I, Wibowo H, Lell B, Sauerwein R, Brice GT, Sutanto I, van Lieshout L, de Craen AJ, van Ree R, Verweij JJ, Tsonaka R, Houwing-Duistermaat JJ, Luty AJ, Sartono E, Supali T, Yazdanbakhsh M
- Issue date: 2013
- The impact of albendazole treatment on the incidence of viral- and bacterial-induced diarrhea in school children in southern Vietnam: study protocol for a randomized controlled trial.
- Authors: Leung JM, Hong CT, Trung NH, Thi HN, Minh CN, Thi TV, Hong DT, Man DN, Knowles SC, Wolbers M, Hoang Nle T, Thwaites G, Graham AL, Baker S
- Issue date: 2016 Jun 6
- Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
- Authors: Walson JL, Otieno PA, Mbuchi M, Richardson BA, Lohman-Payne B, Macharia SW, Overbaugh J, Berkley J, Sanders EJ, Chung MH, John-Stewart GC
- Issue date: 2008 Aug 20